Motif Bio PLC General Meeting -- Dial in Details (6878B)
11 Junio 2021 - 8:59AM
UK Regulatory
TIDMMTFB
RNS Number : 6878B
Motif Bio PLC
11 June 2021
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS
RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN
WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM
AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF IRELAND, THE REPUBLIC OF
SOUTH AFRICA, THE UNITED STATES OF AMERICA OR ANY OTHER
JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION
WOULD BE UNLAWFUL.
THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT
CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION,
OFFER OR ADVICE TO ANY PERSON TO SUBSCRIBE FOR, OTHERWISE ACQUIRE
OR DISPOSE OF ANY SECURITIES IN MOTIF BIO PLC OR ANY OTHER ENTITY
IN ANY JURISDICTION.
Motif Bio plc
("Motif" or the "Company")
General Meeting - Dial in Details
Motif Bio plc (AIM: MTFB), which has been reclassified as an AIM
Rule 15 cash shell, provides Shareholders with details of how they
can join the General Meeting which will take place at 12 p.m. (UK
time) on 14 June 2021 at the offices of Reed Smith LLP, 599
Lexington Avenue, New York, NY 10022, United States.
Any Shareholders wishing to join the General Meeting should use
the following dial in details:
-- Dial in number: +1 (862) 902-0240
-- Passcode: 735-9754
Shareholders are also reminded that as all Resolutions to be
voted on at the General Meeting are conditional, all Resolutions
must be approved for the Acquisition to proceed. Motif Bio plc will
not be able to continue operations in the absence of the
Acquisition. As a result, if all Resolutions are not approved by
Shareholders, it is expected that Motif's AIM Admission will be
cancelled as soon as practicable following the General Meeting and
Shareholders will receive no further value.
Capitalised terms used in this announcement carry the same
meanings as those ascribed to them in the Company's Admission
Document dated 26 May 2021 and/or the Company's announcement of 26
May 2021, unless the context requires otherwise.
For further information please contact:
ir@motifbio.com
Motif Bio plc
Jonathan Gold (Non-Executive Director)
------------------------
SP Angel Corporate Finance LLP (NOMAD
& BROKER) +44 (0) 20 3470 0470
------------------------
David Hignell/Caroline Rowe (Corporate
Finance)
------------------------
Vadim Alexandre/Rob Rees (Sales & Broking)
------------------------
Walbrook PR Ltd. (UK FINANCIAL PR &
IR) +44 (0) 20 7933 8780
------------------------
Paul McManus/ Lianne Cawthorne motifbio@walbrookpr.com
------------------------
Forward-Looking Statements
This announcement may contain forward-looking statements. Words
such as "expects", "anticipates", "may", "should", "would",
"could", "will", "intends", "plans", "believes", "targets",
"seeks", "estimates", "aims", "projects", "pipeline" and variations
of such words and similar expressions are intended to identify such
forward-looking statements and expectations. These statements are
not guarantees of future performance or the ability to identify and
consummate transactions and involve certain risks, uncertainties,
outcomes of negotiations and due diligence and assumptions that are
difficult to predict, qualify or quantify. Therefore, actual
outcomes and results may differ materially from what is expressed
in such forward-looking statements or expectations. Among the
factors that could cause actual results to differ materially are:
the general economic climate, competition, interest rate levels,
loss of key personnel, the result of legal and commercial due
diligence and changes in the legal or regulatory environment.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NOGKZGMVFMZGMZM
(END) Dow Jones Newswires
June 11, 2021 09:59 ET (13:59 GMT)
Motif Bio (LSE:MTFB)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Motif Bio (LSE:MTFB)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024